Targeted Mutagenesis in the Malaria Mosquito Using TALE Nucleases

64Citations
Citations of this article
101Readers
Mendeley users who have this article in their library.

Abstract

Anopheles gambiae, the main mosquito vector of human malaria, is a challenging organism to manipulate genetically. As a consequence, reverse genetics studies in this disease vector have been largely limited to RNA interference experiments. Here, we report the targeted disruption of the immunity gene TEP1 using transgenic expression of Transcription-Activator Like Effector Nucleases (TALENs), and the isolation of several TEP1 mutant A. gambiae lines. These mutations inhibited protein production and rendered TEP1 mutants hypersusceptible to Plasmodium berghei. The TALEN technology opens up new avenues for genetic analysis in this disease vector and may offer novel biotechnology-based approaches for malaria control. © 2013 Smidler et al.

Cite

CITATION STYLE

APA

Smidler, A. L., Terenzi, O., Soichot, J., Levashina, E. A., & Marois, E. (2013). Targeted Mutagenesis in the Malaria Mosquito Using TALE Nucleases. PLoS ONE, 8(8). https://doi.org/10.1371/journal.pone.0074511

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free